FEB 15, 2018 09:00 AM PST

What is a CAR-T cell therapy?

3 8 318

Most people must have heard revolutionary cancer therapy called CAR-T cell therapy, a kind of cancer immunotherapy. It has changed the landscape of cancer therapy and has the potential of curing some of the chemotherapy refractory blood cancer such as acute lymphoblastic leukemia (ALL).
Cancer immunotherapy is not a very new science, but it is the culmination of cumulative knowledge gained through countless experiments in immunology and cancer. In 1893, William Coley's observed reduction in tumor size upon injection of streptococcus bacteria. Giving BCG vaccine in early stage of bladder cancer is a form of oldest cancer immunotherapy which is still used in clinical practice.
T cells are the type of a white blood cell which plays an essential role in mounting an appropriate immune response to either diseased cells (virus-infected or cancer cells) or foreign pathogens. Cytotoxic T cells are central in killing cancerous cells. They recognize cancer cells through a particular receptor called T cell receptor (TCR) which binds to the novel antigen expressed only on cancer cells and thereby killing them. However, cytotoxic T cell which can recognize unique tumor antigen is scarce in number, or sometimes tumor itself create microenvironment to decrease their frequency around the tumor microenvironment. One way to overcome this challenge is to engineer T cells ex-vivo isolated from either blood of the patient or healthy individual. In this method, T cells are engineered to produce a single chain variable fragment of an antibody (chimeric antigen receptor; CAR) which recognizes unique antigen only expressed onto tumor cells, e.g., CD19 in case of ALL. They are expended in large number ex-vivo and injected into the patient, where further proliferation produces more engineered T cells specific to tumor cells. Expended CAR-T cells lead to complete killing of all tumor cells without harming healthy normal cells, unlike conventional cancer treatment where most of the side effects come from the killing of healthy cells. However, there are some challenges associated with CAR-T cell therapy such as cytokine storm and expensive nature of its production. Moreover, they are not currently suitable for solid tumors which constitute the majority of cancer found among the population.
FDA has recently approved two CAR-T cell therapy based on CD19 chimeric antigen receptor to treat ALL and diffuse large B cell lymphoma.
About the Author
  • Biological research scientist by profession with passion to write about science in general.
You May Also Like
JUL 07, 2018
Videos
JUL 07, 2018
Can Sending Plants to Space Reveal a Cancer Treatment?
When plants are grown in a totally different environment, it may stimulate new effects.
JUL 17, 2018
Videos
JUL 17, 2018
About That EM Drive Idea...
Traveling through space requires a lot of fuel, and this limitation defines just how far we can go. Physicists have been experimenting with the ‘impo
JUL 22, 2018
Videos
JUL 22, 2018
Goodbye to Louisiana
One-fourth of Louisiana’s coastline has already disappeared since just the 1930s. Every hour, Louisiana loses about a football field of land to the s
JUL 24, 2018
Chemistry & Physics
JUL 24, 2018
How Does It Taste? Want Some Salt (and Microplastics)?
Looks can be very deceiving: pristine, pure-like grains of sea salt can be the perfect trojan horse for the invasion of the omnipresent environmental villa
JUL 30, 2018
Videos
JUL 30, 2018
Identifying Symptoms of a Heat Stroke
A heat stroke is when the body loses its ability to cool itself and the body’s core temperature becomes dangerously high. For some individuals, a hea
AUG 13, 2018
Videos
AUG 13, 2018
Some Ways of Healing the Brain Actually Damage It
Fixing the body usually involves “doing no harm” since that is part of the Hippocratic Oath doctors take. However, to repair the brain, sometim
Loading Comments...